FDA announces fresh Pune warehouse licence cancellation; Cipla disputes findings

Company says it is reviewing the order and its options.

Ready to listen

SpeedDownload audio

Synthetic narration of the full report. No device voice installation needed. Refer to the text for names and figures.

Made by Alan

2 October 2026 · 1 min read

Article

Report prepared 3 Oct 2026, 5:52 am IST · Event date shown above

AI-generated editorial illustration. Fictional scene; not a photograph of an actual place, event or evidence.

Understand this story

ASAL AI

Editorial summary

Company says it is reviewing the order and its options.

Event / development: 2 Oct 2026
Location: Maharashtra

Use neural AI on this report

Generate a short AI reading note. First use downloads about 290 MB; slower devices may not support it. Questions stay on your device.

Maharashtra’s FDA disclosed on October 2 that it had cancelled drug-sale licences for Cipla Pharma & Life Sciences’ Wadki warehouse in Pune.

The October 1 order followed fresh proceedings after High Court directions. The regulator cited packaging, storage and record-keeping deficiencies.

Cipla told NDTV Profit that the facility follows distribution, storage and digital-record protocols. It said it was reviewing the order and evaluating further options.

Maharashtra